Depression, Anxiety, and the Decline of Physical Functioning over 6 Months in Patients with Heart Failure
|
|
- Claire Maxwell
- 5 years ago
- Views:
Transcription
1 Depression, Anxiety, and the Decline of Physical Functioning over 6 Months in Patients with Heart Failure Biing-Jiun Shen, PhD, Stacy Eisenberg, Uta Maeda, Kristen Farrell, MS, Ernst Schwartz, MD, Frank Penedo, PhD, Eugene Bauerlein, MD, Stephen Mallon, MD University of Southern California & University of Miami
2 Heart Failure (HF) Heart muscles too weak to pump sufficient amount of blood to provide for the body s metabolic needs A diverse, costly, and deadly disorder End stage heart disease Heart transplant
3 Heart Failure Heart Failure The only heart disease that is on the rise Prevalence: 5.7 million in US in 2006 ~550,000 new cases each year A contributing cause of 287,000 deaths in US per year
4 Cardiovascular Disease by Mortality CVD breakdown by mortality rates Congenital Defects 0.5% Artery Disease 4% Rheumatic Heart Disease 0.4% Other 13% High Blood Pressure 6% Heart Failure 6% Coronary Heart Disease (CHD) 53% Stroke 17% Source: AHA,
5 Psychosocial Factors & HF Depression 1 in 5 presents clinically significant depressive symptoms (Rutledge et al, 2006) Predicts higher mortality and more frequent hospitalization (Friedmann et al., 2006; De Jong et al., 2004; Jiang et al., 2001; Sherwood et al., 2007) Anxiety Estimated prevalence 18-64% (Haworth et al, 2005; Friedmann et al., 2006) Predicts higher mortality and more frequent hospitalization (Friedmann et al., 2006; De Jong et al., 2004; Tsuchihashi-Makaya et al., 2009)
6 Social Support Lower mortality (Murberg et al., 2004) c.f. No relationship (Friedmann et al., 2006) Better functioning in daily living activities (Clarke et al., 2000) Improvement of QoL over one year (Bennett et al., 2001) 6
7 HF-Related Physical Health Functioning HF Many severe physical symptoms & limitations Few studies have examined psychosocial factors & HF-related physical functioning
8 Research Questions How common are depression and anxiety in HF patients? Does depression, anxiety, social support predict physical health functioning? Cross-sectional 6-month follow-up Do changes in depression and anxiety predict follow-up physical functioning?
9 METHOD
10 Participants HF Patients >= 18 yo Primary Dx of HF No other life-threatening illnesses No active psychotic symptoms or severe cognitive impairments Participants 238 at baseline, 164 at 6-mo FU 9 died, 15 transplants, 50 failed to respond Dropouts did not differ in demographic, psychosocial and PHF scores except being younger, less likely to be married
11 Measures Physical Health Functioning Minnesota Living with Heart Failure Questionnaire (MLWHFQ) Physical Functioning Subscale Physical difficulties due to HF Fatigue, SOB, climbing stairs, chores, yard work, sitting, lying down to rest, sleeping at night etc. Medical Chart Reviews Cardiac disease history, other medical comorbidities, medication Blood Sample CV risk factors, fasting glucose, lipids
12 Psychosocial Measures Depression: Modified Centers for Epidemiologic Studies Depression Scale (CES-D) - 7 somatic symptoms: fatigue, effort, bothered, appetite, sleep, talking less, concentration Anxiety: Hospital Anxiety and Depression Scale (HADS) Social Support: MOS Social Support Survey
13 Demographic Characteristics (N = 164) Gender Marital Status Age = 55.4 (10.4) yrs Wom en 34% Men % Not Partnered 44% Partnered 56% Education Ethnicity >= College 20% < HS 15% Other 5% White 26% Some College HS 34% Hispanic 44% Black 24%
14 Medical Characteristics Mean LVEF = 26% (13%) NYHA Class Time since HF diagnosis: 78 (SD=93) months Class 4 6% Class 1 14% Class 3 36% Class 2 44% 14
15 Participant Characteristics CV Risk Factors and Health Behaviors Weight (in kg) 87 ± 19 BMI (kg/m 2 ) ± 6.39 SBP (mmhg) 117 ± 21 DBP (mmhg) 74 ± 11 % Hypertension 68% % Dyslipidemia 49% % Diabetes 33% % Current smoking 6% % Current alcohol use 27%
16 MAIN FINDINGS
17 Prevalence of Depression & Anxiety Depression (CES-D) Moderate- Severe 24% No 51% Anxiety (HADS) Mild 25% Severe 19% No 55% Borderline 26%
18 Concurrent Associations Baseline Psychosocial Factors & Physical Health Functioning Baseline physical functioning Depression β =.401, p <.001 β =.245, p =.001 Anxiety β =.421, p <.001 β =.246, p =.002 Social support β = -.059, p =.321 β = -.040, p =.455 Analyses adjusted for age, gender, marital status, education, NYHA class, treatment for depression or anxiety, and use of ACE inhibitor
19 Prospective Relationships Psychosocial Factors & Physical Health Functioning at 6 Months 6-month Physical Functioning Depression β =.154, p =.016 Ns Anxiety β =.207, p =.001 β =.279, p=.035 Social support β = -.029, p =.614 Ns Analyses adjusted for age, gender, marital status, education, NYHA class, treatment for depression or anxiety, and use of ACE inhibitor
20 Correlations Depression Depression Dep change Anxiety Anxiety change Depression change -.431(**).000 Anxiety.746(**) -.226(**) Anxiety change -.223(**).502(**) -.466(**) ** Correlation is significant at the 0.01 level (2-tailed). 20
21 Change in Depression & 6-Mo Physical Functioning Psychological Factor 6-Month Physical Health Functioning Depression at baseline β =.288, p <.001 Change in depression over 6 mo β =.276, p <.001 Anxiety at baseline β =.318, p <.001 Change in anxiety over 6 mo β =.230, p <.001 Social support at baseline β = -.031, p =.635 Change in social support over 6 months β = -.005, p =.860 Models adjusted for age, gender, marital status, education, NYHA class, treatment for depression or anxiety, and baseline physical functioning
22 Change in Anxiety & 6-Mo Physical Functioning Psychological Factor 6-Month Physical Health Functioning Depression at baseline β =.288, p <.001 Change in depression over 6 mo β =.276, p <.001 Anxiety at baseline β =.318, p <.001 Change in anxiety over 6 mo β =.230, p <.001 Social support at baseline β = -.031, p =.635 Change in social support over 6 months β = -.005, p =.860 Models adjusted for age, gender, marital status, education, NYHA class, treatment for depression or anxiety, and baseline physical functioning
23 Change in Social Support & 6-Mo Physical Functioning Psychological Factor 6-Month Physical Health Functioning Depression at baseline β =.288, p <.001 Change in depression over 6 mo β =.276, p <.001 Anxiety at baseline β =.318, p <.001 Change in anxiety over 6 mo β =.230, p <.001 Social support at baseline β = -.031, p =.635 Change in social support over 6 months β = -.005, p =.860 Models adjusted for age, gender, marital status, education, NYHA class, treatment for depression or anxiety, and baseline physical functioning
24 Summary Depression and anxiety symptoms are prevalent and fairly severe in HF patients Depression and anxiety decline of physical health functioning Increases in depression and anxiety further declines Social support? Assessing and treating emotional distress in HF patients may facilitate better management of their illness
25 Acknowledgement Tiffany Ju Annia Rodriguez Karen Irani Eliana Reyes Armando Mendez, PhD
Avoidant Coping Moderates the Association between Anxiety and Physical Functioning in Patients with Chronic Heart Failure
Avoidant Coping Moderates the Association between Anxiety and Physical Functioning in Patients with Chronic Heart Failure Eisenberg SA 1, Shen BJ 1, Singh K 1, Schwarz ER 2, Mallon SM 3 1 University of
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.
Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not
More informationCardiovascular Risk Assessment and Management Making a Difference
Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationStandards of Medical Care in Diabetes 2016
Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking
More informationAndrew J. Dimond, David S. Krantz, Andrew J. Waters, Romano Endrighi, Stephen S. Gottlieb
Andrew J. Dimond, David S. Krantz, Andrew J. Waters, Romano Endrighi, Stephen S. Gottlieb Uniformed Services University, Bethesda MD and University of Maryland Hospital, Baltimore MD Heart Failure Serious
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationHF-PEF: Symptoms, quality of life and mortality/morbidity
HF-PEF: Symptoms, quality of life and mortality/morbidity May 21, 2011 John McMurray, MD Eugene Braunwald Scholar in Cardiovascular Diseases, Brigham & Women s Hospital Boston; Visiting Professor of Medicine,
More informationDoes quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)?
Does quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)? Erika Friedmann a, Eleanor Schron, b Sue A. Thomas a a University of Maryland School of Nursing; b NEI, National
More informationPatient is healthy with no chronic disease or significant risk factors [16%].
AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationValue of cardiac rehabilitation Prof. Dr. L Vanhees
Session: At the interface of hypertension and coronary heart disease haemodynamics, heart and hypertension Value of cardiac rehabilitation Prof. Dr. L Vanhees ESC Stockholm August 2010 Introduction There
More informationClaudication Treatment Comparative Effectiveness: 6 Month Outcomes from the CLEVER Study
Claudication Treatment Comparative Effectiveness: 6 Month Outcomes from the CLEVER Study Authors: Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DC, Reynolds MR, Lewis BA, Cerezo J, Oldenburg
More informationPROMIS-29 V2.0 Physical and Mental Health Summary Scores. Ron D. Hays. Karen L. Spritzer, Ben Schalet, Dave Cella. September 27, 2017, 3:30-4:00pm
PROMIS-29 V2.0 Physical and Mental Health Summary Scores Ron D. Hays Karen L. Spritzer, Ben Schalet, Dave Cella September 27, 2017, 3:30-4:00pm HealthMeasures User Conference Track B: Enhancing Quality
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationCorrelation of novel cardiac marker
Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationHeart 101. Objectives. Types of Heart Failure How common is HF? Sign/Symptoms, when to see a doctor? Diagnostic testing
EXAMING HEART FAILURE: HOW TO RECOGNIZE AND TREAT THE WEAK HEART What is Heart Failure? Treatment of Heart Failure End Stage Heart Failure Munir S. Janmohamed M.D. FACC Assistant Clinical Professor of
More informationThe Road to Improve Cardiovascular Health after Cancer. S. Carolina Masri, MD Cardiology Division University of Washington, Seattle June 2 nd 2018
The Road to Improve Cardiovascular Health after Cancer S. Carolina Masri, MD Cardiology Division University of Washington, Seattle June 2 nd 2018 Objective What are the cardiac complications in cancer
More informationNew PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.
New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. Measure Steward Measure Name Measure Description Rationale for Adding
More informationBlood Pressure Measurement in SPRINT
Blood Pressure Measurement in SPRINT Karen C. Johnson, MD, MPH, FAHA Vice Chair, SPRINT Steering Committee University of Tennessee Health Science Center, Department of Preventive Medicine For the SPRINT
More informationProfessor Norman Sharpe. Heart Foundation West Coast
Professor Norman Sharpe Heart Foundation West Coast Primary Care the Keystone to Heart Health Improvement Norman Sharpe June 2013 The heart health continuum and the keystone position The culprit disease
More informationBlood Pressure Acre Surgery Diviash Thakrar
Blood Pressure Acre Surgery Diviash Thakrar Why Are We Doing This? 1. Improve education for patients within the practice 2. Allow us use this for general health promotion Raise money for charity 3. Raise
More informationEXS 145 Guidelines for Exercise Testing & Prescription
EXS 145 Guidelines for Exercise Testing & Prescription 11-3-11 Andrew Weiler M.Ed MCCD Adjunct Faculty CGCC Employee Wellness Coordinator SRPMIC Employee Wellness Coordinator Pot & Window LLC Today How
More informationWhat is hypertension?
HYPERTENSION What is hypertension? Abnormally elevated arterial blood pressure that is usually indicated by an adult systolic blood pressure of 140 mm Hg or greater or a diastolic blood pressure of 90
More informationShiftwork and cardiometabolic outcomes. Dr Anil Adisesh
Shiftwork and cardiometabolic outcomes Dr Anil Adisesh 1 FACULTY/PRESENTER DISCLOSURE Faculty: Dr Anil Adisesh Relationships with commercial interests: - None 2 Aims 1) Participants will be able to describe
More informationPermission Granted!! Women Take Care of Your Hearts! October 22, 2016
Associate Director of Clinical Trials Division of Cardiovascular Medicine University of Florida 1 1. Cancer 2. Housework 3. Heart Disease 4. Children who don t leave home 5. 2, 3, 4 10/25/2016 12:36 PM
More informationMEXICAN- AND ANGLO-AMERICANS IN CARDIO REHABILITATION: DO CULTURAL DIFFERENCES MAKE A DIFFERENCE?
MEXICAN- AND ANGLO-AMERICANS IN CARDIO REHABILITATION: DO CULTURAL DIFFERENCES MAKE A DIFFERENCE? Ada Wilkinson-Lee, Michael J. Rohrbaugh, Joshua Schoenfeld, and Varda Shoham University of Arizona National
More informationHypertension Guidelines 2017
Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,
More informationBlood Pressure LIMBO How Low To Go?
Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity
More informationAdvanced Care for Decompensated Heart Failure
Advanced Care for Decompensated Heart Failure Sara Kalantari MD Assistant Professor of Medicine, University of Chicago Advanced Heart Failure, Mechanical Circulatory Support and Cardiac Transplantation
More informationCoronary Heart Disease in Women Go Red for Women
Coronary Heart Disease in Women Go Red for Women Dr Fiona Stewart Green Lane Cardiovascular Service and National Women s Health Auckland City Hospital Auckland Heart Group Women are Different from Men
More informationHypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic
Hypertension in 2015: SPRINT-ing ahead of JNC-8 MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Conflits of interest? None Disclaimer The opinions contained herein are not to be considered
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationDisclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?
Disclosures JUPITER: The final frontier in statin utilization or an idea from outer space? Kathy E. Komperda, PharmD, BCPS Midwestern University Chicago College of Pharmacy kkompe@midwestern.edu 4/25/09
More informationEugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG
Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System
More informationWhat s the evidence, why do guidelines differ, and what should the GP do?
What s the evidence, why do guidelines differ, and what should the GP do? Richard McManus Barcelona 2018 Overview What is hypertension? How should blood pressure be measured/diagnosed? What should we be
More informationIdentification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study
Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Dr. Antonio Magaña M.D. (on behalf I-PREFER investigators group) Stockholm, Sweden, August
More informationStroke secondary prevention. Gill Cluckie Stroke Nurse Consultant St. George s Hospital
Stroke secondary prevention Gill Cluckie Stroke Nurse Consultant St. George s Hospital Stroke recurrence The risk of recurrent stroke is greatest after first stroke 2 3% of survivors of a first stroke
More informationBenefits of Combined Aerobic/Resistance/Inspiratory Muscle Training in Patients with Chronic Heart Failure. The Ideal Exercise Program for CHF?
Benefits of Combined Aerobic/Resistance/Inspiratory Muscle Training in Patients with Chronic Heart Failure. The Ideal Exercise Program for CHF? I D. Laoutaris, S Adamopoulos, A Manginas, D B. Panagiotakos,
More informationHypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy
Hypertension Update Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Introduction 1/3 of US adults have HTN More prevalent in non-hispanic
More informationPrevention of MACROvascular Complications of Diabetes
Prevention of MACROvascular Complications of Diabetes Matt Bouchonville, MD, CDE Endocrinology Division University of New Mexico School of Medicine July 12, 2018 Conflicts of Interest None Objectives 1.
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationThe RealiseAF registry:
The RealiseAF registry: An International, observational, cross-sectional survey evaluating atrial fibrillation management and the cardiovascular risk profile of AF patients initial results PG.Steg on behalf
More informationLecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors
Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationThe Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine
The Heart of a Woman Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine American Heart Association Women, Heart Disease and Stroke
More informationQuality of Life in Pediatric VAD- How are we doing?
Quality of Life in Pediatric VAD- How are we doing? INTERMACS Eighth Annual Meeting May 5, Karen Uzark, PhD, CPNP University of Michigan Congenital Heart Center Definitions HEALTH = not only the absence
More informationA n aly tical m e t h o d s
a A n aly tical m e t h o d s If I didn t go to the screening at Farmers Market I would not have known about my kidney problems. I am grateful to the whole staff. They were very professional. Thank you.
More informationThe Role of Cardiac Rehabilitation in Recovery & Secondary Prevention. Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager
The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager Objectives Core Components of Cardiac Rehab Program CR Indications &
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationHigh intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes
High intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes Sophie Cassidy, s.cassidy@ncl.ac.uk 1) Concentric remodelling 1.2 * Eccentricity ratio
More informationwell-targeted primary prevention of cardiovascular disease: an underused high-value intervention?
well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? Rod Jackson University of Auckland, New Zealand October 2015 Lancet 1999; 353: 1547-57 Findings: Contribution
More informationProf. Renata Cífková, MD, CSc.
Prof. Renata Cífková, MD, CSc. Head of the Department of Preventive Cardiology, Thomayer Teaching Hospital, Prague Focuses on arterial hypertension epidemiology, clinical trials, target organ damage prevention
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationEndothelial function is impaired in women who had pre-eclampsia
Endothelial function is impaired in women who had pre-eclampsia Christian Delles, Catriona E Brown, Joanne Flynn, David M Carty Institute of Cardiovascular and Medical Sciences University of Glasgow United
More informationHow do we define ethnic healthcare disparities? Ethnic Disparity. Cardiovascular Disease in Asians: Are Asians at Increased Risk?
Cardiovascular Disease in Asians: Are Asians at Increased Risk? November 17, 2007 Gordon L. Fung, MD, MPH, PhD, FACC, FAHA, FACP Director, Asian Heart & Vascular Center Clinical Professor of Medicine UCSF
More informationDiabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?
Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of
More informationDEPARTMENT OF GENERAL MEDICINE WELCOMES
DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global
More informationRikshospitalet, University of Oslo
Rikshospitalet, University of Oslo Preventing heart failure by preventing coronary artery disease progression European Society of Cardiology Dyslipidemia 29.08.2010 Objectives The trends in cardiovascular
More informationTreating Hypertension in 2018: What Makes the Most Sense Today?
Treating Hypertension in 2018: What Makes the Most Sense Today? Daniel Blanchard, MD Professor of Medicine UC San Diego Cardiovascular Center La Jolla, California 1 2 Speaker Disclosures Consultant and/or
More informationValidity and reliability of a 36-item problemrelated distress screening tool in a community sample of 319 cancer survivors
Validity and reliability of a 36-item problemrelated distress screening tool in a community sample of 319 cancer survivors Melissa Miller 1, Joanne Buzaglo 1, Kasey Dougherty 1, Vicki Kennedy 1, Julie
More informationHEART DISEASE HEART CONDITIONS, RISKS AND PROTECTION
Spotlight on Health 2017 HEART DISEASE HEART CONDITIONS, RISKS AND PROTECTION Heart disease is the leading cause of death for both men and women worldwide, accounting for over 17 million deaths per year.
More informationCurrent status on other health effects:
Current status on other health effects: Changes in Cardiovascular Risk Factors after the Great East Japan Earthquake Tetsuya Ohira, MD, PhD. Department of Epidemiology, Fukushima Medical University School
More informationDEPRESSIVE SYMPTOMS ARE ASSOCIATED WITH HIGHER LEVELS OF PEAK PLASMA GLUCOSE CONCENTRATIONS IN HISPANICS WITH METABOLIC SYNDROME.
DEPRESSIVE SYMPTOMS ARE ASSOCIATED WITH HIGHER LEVELS OF PEAK PLASMA GLUCOSE CONCENTRATIONS IN HISPANICS WITH METABOLIC SYNDROME. Orit Birnbaum-Weitzman, Ph.D. University of Miami Ron Goldberg, M.D. Barry
More informationPERFORMANCE AFTER HSCT Mutlu arat, md ıstanbul bilim un., dept. hematology ıstanbul, turkey
PERFORMANCE AFTER HSCT Mutlu arat, md ıstanbul bilim un., dept. hematology ıstanbul, turkey Joint Educational Meeting of the EBMT Severe Aplastic Anaemia, Late Effects and Autoimmune Diseases Working Parties
More informationDemographic and Diagnostic Profile of Study Participants
Demographic and Diagnostic Profile of Study Participants Enrollment Progress to Date 1,792 participants enrolled as of July 26 th 588 Full-Service participants 606 Basic-Service participants 598 Usual
More informationCITY OF HOPE NATIONAL MEDICAL CENTER QUALITY OF LIFE QUESTIONNAIRE FOR PATIENTS WITH AN OSTOMY
ID # CITY OF HOPE NATIONAL MEDICAL CENTER QUALITY OF LIFE QUESTIONNAIRE FOR PATIENTS WITH AN OSTOMY In advance, thank you for taking the time to complete this questionnaire. We want to ensure that your
More informationHow does depression affect self-care?
How does depression affect self-care? I. Lesman-Leegte, Department of Cardiology University Medical Centre Groningen The Netherlands g.a.t.lesman-leegte@thorax.umcg.nl The University Medical Centre Groningen
More informationMental health practitioners working in medicine represent the vanguard
Series Foreword Mental health practitioners working in medicine represent the vanguard of psychological practice. As scientific discovery and advancement in medicine has rapidly evolved in recent decades,
More informationHypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute
Hypertension Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute Hypertension 2017 Classification BP Category Systolic Diastolic Normal 120 and 80 Elevated
More informationDepressive Symptom Dimensions and Cardiovascular Prognosis among Women with Suspected Myocardial Ischemia
Depressive Symptom Dimensions and Cardiovascular Prognosis among Women with Suspected Myocardial Ischemia A Report from the NHLBI- Sponsored Women s Ischemia Syndrome Evaluation (WISE) Society of Behavioral
More informationRoadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total
Diabetes and the Metabolic Syndrome in the Asian Population Alka Kanaya, MD Associate Professor of Medicine, UCSF Feb 26, 2010 Roadmap 1. Diabetes in Asian Americans Prevalence in the U.S. Risk factors
More informationUnderstanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s
Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Ho Chi Minh City, Vietnam August 7, 2014 JBS 2 Risk Guidelines (2005) Based
More informationLack of documentation on overweight & obese status in patients admitted to the coronary care unit: Results from the CCU study
Lack of documentation on overweight & obese status in patients admitted to the coronary care unit: Results from the CCU study Meriam F. Caboral,, RN, MSN, NP-C Clinical Coordinator Heart Failure Components
More informationPAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only)
PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only) 1. What is the main problem that you are having? (If additional space is required, please use the back of this
More informationA national survey of cardiac rehabilitation programs in Australia: Program characteristics and psychosocial screening practices
Improving the lives of people with heart disease A national survey of cardiac rehabilitation programs in Australia: Program characteristics and psychosocial screening practices Report to ACRA in compliance
More informationPrimary Physiological
Appendix Table 3. Primary outcomes and effect sizes for trials included in review. Trial Behavior Outcome Effect size Group difference in original units Primary Physiological ACT 22, a Be Fit, Be Well
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationKey causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about:
Preventive care - Chronic Disease Management in primary care: a population perspective Rod Jackson University of Auckland New Zealand (22/11/8) Key causes of preventable deaths in New Zealand In a population
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationWomen and Vascular Disease
Women and Vascular Disease KEVIN F. REBECK PA-C VASCULAR TRANSPLANT SURGERY 1 The Scope of the Problem One woman dies every minute from cardiovascular disease in the U.S.! The Scope of the Problem CVD
More informationHeart Disease in Women. Charlotte A. Lee, M.D., DBIM, FLMI
Heart Disease in Women Charlotte A. Lee, M.D., DBIM, FLMI Heart Disease in Women Congenital Heart Disease Valvular Heart Disease Arrhythmias Cardiomyopathy Hypertension Coronary Artery Disease Coronary
More informationThe Latest Generation of Clinical
The Latest Generation of Clinical Guidelines: HTN and HLD Dave Brackett Clinical Guideline Purpose Uniform approach Awareness of key details Diagnosis Treatment Monitoring Evidence based approach Inform
More informationThe Role of Cardiac Rehabilitation. The Role of Cardiac Rehabilitation. in Heart Failure. in Heart Failure. History of Cardiac Rehab.
The Role of Cardiac Rehabilitation The Role of Cardiac Rehabilitation in Heart Failure in Heart Failure Kate Traynor RN MS FAACVPR Financial Disclosures No relevant financial relationship exists. History
More informationPortable Sleep Testing in Hospitalized Patients
1 Portable Sleep Testing in Hospitalized Patients Rami Khayat, MD Heart Failure AND Public Health 6 million Americans with heart failure (>2% population 20 million people with asymptomatic cardiac impairment
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationYuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China
What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4
More informationLow-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies
Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies Mohsen Mazidi 1, Niki Katsiki 2, Dimitri P. Mikhailidis 3, Maciej Banach
More information10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor
Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationDrugs acting on the reninangiotensin-aldosterone
Drugs acting on the reninangiotensin-aldosterone system John McMurray Eugene Braunwald Scholar in Cardiovascular Diseases, Brigham and Women s Hospital, Boston & Visiting Professor, Harvard Medical School
More informationAtrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice
Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice Walid Saliba, MD, FHRS Director, Atrial Fibrillation Center Director EP laboratory Heart and Vascular Institute Cleveland
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,
More informationConflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines
Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy
More informationPut your Heart before your Head
Put your Heart before your Head Alok K Gupta, MD, FAAFP, FASH Associate Professor, Outpatient Clinic since 1963, the US Congress has required the President to proclaim February "American Heart Month."
More informationLifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study
Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study Harvey White Green Lane Cardiovascular Service and Cardiovascular
More information